Financials in USD. Standardized financial statements.
A compact view of how Healthcare Triangle, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $13.89M | $11.70M | $33.20M | $45.89M | $35.27M | $31.34M | $28.74M |
| Revenue Growth? | +18.8% | -64.8% | -27.6% | +30.1% | +12.5% | +9.1% | 0.0% |
| Cost of Revenue? | $12.00M | $8.81M | $26.43M | $34.59M | $24.75M | $23.56M | $23.66M |
| Gross Profit? | $1.89M | $2.89M | $6.78M | $11.29M | $10.52M | $7.78M | $5.07M |
| Gross Margin? | +13.6% | +24.7% | +20.4% | +24.6% | +29.8% | +24.8% | +17.7% |
| Operating Expenses? | $11.68M | $7.64M | $14.47M | $27.62M | $15.88M | $6.61M | $3.40M |
| Operating Income? | -$9.79M | -$4.75M | -$7.70M | -$16.32M | -$5.36M | $1.18M | $1.67M |
| EBITDA? | -$9.08M | -$3.85M | -$6.12M | -$10.70M | -$3.94M | $1.98M | $2.45M |
| Income Before Tax | -$9.48M | -$5.96M | -$8.65M | -$13.85M | -$5.92M | $2.61M | $1.62M |
| Income Tax Expense | $0 | $12,000 | $35,000 | $506,000 | $24,000 | $257,381 | $444,371 |
| Net Income? | -$9.48M | -$5.97M | -$8.69M | -$14.36M | -$5.95M | $2.35M | $1.17M |
| EPS? | $-15308.56 | $-16895.02 | $-31051.57 | $-57997.93 | $-30202.01 | $9993.37 | $4976.51 |
| Diluted EPS? | $-15308.56 | $-16895.02 | $-31051.57 | $-57997.93 | $-30202.01 | $9993.37 | $4976.51 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality